BioEnvelop Gains Registration with Health Canada for Manufacturing of Natural Health Products

BioEnvelop Gains Registration with Health Canada for Manufacturing of Natural Health Products Company has received a license to manufacture under the Natural Health Products (NHP) certification program of Canada.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Nutraceutical Clinical Laboratories International, Inc., Secures $2 Million in Funding KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava Major Weight-Loss Marketers Pay $3 Million Sellers making questionable weight-loss and fat-loss claims to peddle skin gels and diet supplements will pay $3 million to settle Federal Trade Commission charges that their deceptive claims violated federal law, with the sttlements barring unsubstantiated claims in the future and bars the marketers from misrepresenting studies or endorsements. AHPA NDI Tele-Seminar Includes Essential Guidance Documents, NDI Database Subscription Discounts This week’s tele-seminar, Navigating FDA’s New Dietary Ingredient Notification Requirements, (May 19, 2006) will premiere the American Herbal Product Association's new Interim Guidance for New Dietary Ingredient Notifications for Manufacturers or Distributors of New Dietary Ingredients. AHPA NDI Tele-Seminar Includes Essential Guidance Documents, NDI Database Subscription Discounts This week’s tele-seminar, Navigating FDA’s New Dietary Ingredient Notification Requirements, (May 19, 2006) will premiere the American Herbal Product Association's new Interim Guidance for New Dietary Ingredient Notifications for Manufacturers or Distributors of New Dietary Ingredients. AHPA NDI Tele-Seminar Includes Essential Guidance Documents, NDI Database Subscription Discounts This week’s tele-seminar, Navigating FDA’s New Dietary Ingredient Notification Requirements, (May 19, 2006) will premiere the American Herbal Product Association's new Interim Guidance for New Dietary Ingredient Notifications for Manufacturers or Distributors of New Dietary Ingredients. AHPA NDI Tele-Seminar Includes Essential Guidance Documents, NDI Database Subscription Discounts This week’s tele-seminar, Navigating FDA’s New Dietary Ingredient Notification Requirements, (May 19, 2006) will premiere the American Herbal Product Association's new Interim Guidance for New Dietary Ingredient Notifications for Manufacturers or Distributors of New Dietary Ingredients. CRN Responds To Panel Report On Multivitamins Organization responds to the report presented by the scientific panel at the NIH State-of-the-Science Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention held this week in Bethesda, Md. CRN Responds To Panel Report On Multivitamins Organization responds to the report presented by the scientific panel at the NIH State-of-the-Science Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention held this week in Bethesda, Md. European Parliament Passes Second Reading on Health and Nutrition Claims The European Parliament has passed second reading of the Health and Nutrition Claims Regulation which will govern permitted health and nutrition claims allowable in the European Union. The regulations, incorporating compromise amendments introduced prior to this reading, are expected to be formally adopted by this autumn. The regulation includes strict conditions for nutrition claims, an initial positive list of approved health claims (after which claims submitted will have to be reviewed by the European Food Safety Authority (EFSA) and then approved by the Commission and Member States), and the use of new health claims or disease reduction claims will require specific authorization after scientific assessment and verification. European Parliament Passes Second Reading on Health and Nutrition Claims The European Parliament has passed second reading of the Health and Nutrition Claims Regulation which will govern permitted health and nutrition claims allowable in the European Union. The regulations, incorporating compromise amendments introduced prior to this reading, are expected to be formally adopted by this autumn. The regulation includes strict conditions for nutrition claims, an initial positive list of approved health claims (after which claims submitted will have to be reviewed by the European Food Safety Authority (EFSA) and then approved by the Commission and Member States), and the use of new health claims or disease reduction claims will require specific authorization after scientific assessment and verification. European Parliament Passes Second Reading on Health and Nutrition Claims The European Parliament has passed second reading of the Health and Nutrition Claims Regulation which will govern permitted health and nutrition claims allowable in the European Union. The regulations, incorporating compromise amendments introduced prior to this reading, are expected to be formally adopted by this autumn. The regulation includes strict conditions for nutrition claims, an initial positive list of approved health claims (after which claims submitted will have to be reviewed by the European Food Safety Authority (EFSA) and then approved by the Commission and Member States), and the use of new health claims or disease reduction claims will require specific authorization after scientific assessment and verification. European Parliament Passes Second Reading on Health and Nutrition Claims The European Parliament has passed second reading of the Health and Nutrition Claims Regulation which will govern permitted health and nutrition claims allowable in the European Union. The regulations, incorporating compromise amendments introduced prior to this reading, are expected to be formally adopted by this autumn. The regulation includes strict conditions for nutrition claims, an initial positive list of approved health claims (after which claims submitted will have to be reviewed by the European Food Safety Authority (EFSA) and then approved by the Commission and Member States), and the use of new health claims or disease reduction claims will require specific authorization after scientific assessment and verification. European Parliament Passes Second Reading on Health and Nutrition Claims The European Parliament has passed second reading of the Health and Nutrition Claims Regulation which will govern permitted health and nutrition claims allowable in the European Union. The regulations, incorporating compromise amendments introduced prior to this reading, are expected to be formally adopted by this autumn. The regulation includes strict conditions for nutrition claims, an initial positive list of approved health claims (after which claims submitted will have to be reviewed by the European Food Safety Authority (EFSA) and then approved by the Commission and Member States), and the use of new health claims or disease reduction claims will require specific authorization after scientific assessment and verification. European Parliament Passes Second Reading on Health and Nutrition Claims The European Parliament has passed second reading of the Health and Nutrition Claims Regulation which will govern permitted health and nutrition claims allowable in the European Union. The regulations, incorporating compromise amendments introduced prior to this reading, are expected to be formally adopted by this autumn. The regulation includes strict conditions for nutrition claims, an initial positive list of approved health claims (after which claims submitted will have to be reviewed by the European Food Safety Authority (EFSA) and then approved by the Commission and Member States), and the use of new health claims or disease reduction claims will require specific authorization after scientific assessment and verification. European Parliament Passes Second Reading on Health and Nutrition Claims The European Parliament has passed second reading of the Health and Nutrition Claims Regulation which will govern permitted health and nutrition claims allowable in the European Union. The regulations, incorporating compromise amendments introduced prior to this reading, are expected to be formally adopted by this autumn. The regulation includes strict conditions for nutrition claims, an initial positive list of approved health claims (after which claims submitted will have to be reviewed by the European Food Safety Authority (EFSA) and then approved by the Commission and Member States), and the use of new health claims or disease reduction claims will require specific authorization after scientific assessment and verification. European Parliament Passes Second Reading On Fortified Foods Regulations The European Parliament voted yesterday on EU Fortified Foods Regulations yesterday, with the objective of laying down common EU rules on the addition of vitamins, minerals and other substances to foods. The rules will apply in 6 months, although for a period of three years afterwards, products not in compliance can be marketed, if they were labeled or placed into the market prior to the regulations coming into force. The regulations call for an approved list of vitamins and minerals, with others not on the list allowable if on the market at the time the regulations coming into force and use supported by dossiers to be transferred to the European Food Safety Authority (EFSA) for evaluation. The Comiology procedure, based on scientific advice from EFSA will be used for determining minimum and maximum levels. European Parliament Passes Second Reading On Fortified Foods Regulations The European Parliament voted yesterday on EU Fortified Foods Regulations yesterday, with the objective of laying down common EU rules on the addition of vitamins, minerals and other substances to foods. The rules will apply in 6 months, although for a period of three years afterwards, products not in compliance can be marketed, if they were labeled or placed into the market prior to the regulations coming into force. The regulations call for an approved list of vitamins and minerals, with others not on the list allowable if on the market at the time the regulations coming into force and use supported by dossiers to be transferred to the European Food Safety Authority (EFSA) for evaluation. The Comiology procedure, based on scientific advice from EFSA will be used for determining minimum and maximum levels. European Parliament Passes Second Reading On Fortified Foods Regulations The European Parliament voted yesterday on EU Fortified Foods Regulations yesterday, with the objective of laying down common EU rules on the addition of vitamins, minerals and other substances to foods. The rules will apply in 6 months, although for a period of three years afterwards, products not in compliance can be marketed, if they were labeled or placed into the market prior to the regulations coming into force. The regulations call for an approved list of vitamins and minerals, with others not on the list allowable if on the market at the time the regulations coming into force and use supported by dossiers to be transferred to the European Food Safety Authority (EFSA) for evaluation. The Comiology procedure, based on scientific advice from EFSA will be used for determining minimum and maximum levels. European Parliament Passes Second Reading On Fortified Foods Regulations The European Parliament voted yesterday on EU Fortified Foods Regulations yesterday, with the objective of laying down common EU rules on the addition of vitamins, minerals and other substances to foods. The rules will apply in 6 months, although for a period of three years afterwards, products not in compliance can be marketed, if they were labeled or placed into the market prior to the regulations coming into force. The regulations call for an approved list of vitamins and minerals, with others not on the list allowable if on the market at the time the regulations coming into force and use supported by dossiers to be transferred to the European Food Safety Authority (EFSA) for evaluation. The Comiology procedure, based on scientific advice from EFSA will be used for determining minimum and maximum levels. European Parliament Passes Second Reading On Fortified Foods Regulations The European Parliament voted yesterday on EU Fortified Foods Regulations yesterday, with the objective of laying down common EU rules on the addition of vitamins, minerals and other substances to foods. The rules will apply in 6 months, although for a period of three years afterwards, products not in compliance can be marketed, if they were labeled or placed into the market prior to the regulations coming into force. The regulations call for an approved list of vitamins and minerals, with others not on the list allowable if on the market at the time the regulations coming into force and use supported by dossiers to be transferred to the European Food Safety Authority (EFSA) for evaluation. The Comiology procedure, based on scientific advice from EFSA will be used for determining minimum and maximum levels. European Parliament Passes Second Reading On Fortified Foods Regulations The European Parliament voted yesterday on EU Fortified Foods Regulations yesterday, with the objective of laying down common EU rules on the addition of vitamins, minerals and other substances to foods. The rules will apply in 6 months, although for a period of three years afterwards, products not in compliance can be marketed, if they were labeled or placed into the market prior to the regulations coming into force. The regulations call for an approved list of vitamins and minerals, with others not on the list allowable if on the market at the time the regulations coming into force and use supported by dossiers to be transferred to the European Food Safety Authority (EFSA) for evaluation. The Comiology procedure, based on scientific advice from EFSA will be used for determining minimum and maximum levels. European Parliament Passes Second Reading On Fortified Foods Regulations The European Parliament voted yesterday on EU Fortified Foods Regulations yesterday, with the objective of laying down common EU rules on the addition of vitamins, minerals and other substances to foods. The rules will apply in 6 months, although for a period of three years afterwards, products not in compliance can be marketed, if they were labeled or placed into the market prior to the regulations coming into force. The regulations call for an approved list of vitamins and minerals, with others not on the list allowable if on the market at the time the regulations coming into force and use supported by dossiers to be transferred to the European Food Safety Authority (EFSA) for evaluation. The Comiology procedure, based on scientific advice from EFSA will be used for determining minimum and maximum levels. Sageant Leads Grassroots Response to FTC Rule That Threatens Network Marketing Sageant has launched a national grassroots campaign to secure responses to the recently proposed Federal Trade Commission (FTC) new rule on business opportunities. Sageant Leads Grassroots Response to FTC Rule That Threatens Network Marketing Sageant has launched a national grassroots campaign to secure responses to the recently proposed Federal Trade Commission (FTC) new rule on business opportunities. NNFA Statement in Response to NIH State-of-the-Science Conference on Multivitamin/Mineral Supplements In response to findings by the State-of-the-Science Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention, the National Nutritional Foods Association (NNFA) maintains that multivitamins and other mineral supplements taken by more than 100 million Americans daily are a safe, affordable and effective way to maintain a healthy lifestyle. NNFA Statement in Response to NIH State-of-the-Science Conference on Multivitamin/Mineral Supplements In response to findings by the State-of-the-Science Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention, the National Nutritional Foods Association (NNFA) maintains that multivitamins and other mineral supplements taken by more than 100 million Americans daily are a safe, affordable and effective way to maintain a healthy lifestyle. NNFA Statement in Response to NIH State-of-the-Science Conference on Multivitamin/Mineral Supplements In response to findings by the State-of-the-Science Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention, the National Nutritional Foods Association (NNFA) maintains that multivitamins and other mineral supplements taken by more than 100 million Americans daily are a safe, affordable and effective way to maintain a healthy lifestyle. NNFA Statement in Response to NIH State-of-the-Science Conference on Multivitamin/Mineral Supplements In response to findings by the State-of-the-Science Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention, the National Nutritional Foods Association (NNFA) maintains that multivitamins and other mineral supplements taken by more than 100 million Americans daily are a safe, affordable and effective way to maintain a healthy lifestyle. FDA Finalizes Health Claim Associating Consumption of Barley Products with Reduction of Risk of Coronary Heart Disease The Food and Drug Administration announced that it has finalized a rule that allows foods containing barley to claim that they reduce the risk of coronary heart disease. whole grain barley and dry milled barley products such as flakes, grits, flour, and pearled barley, which provide at least 0.75 grams of soluble fiber per serving, may bear the following claim: ""Soluble fiber from foods such as [name of food], as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. A serving of [name of food] supplies [x] grams of the soluble fiber necessary per day to have this effect." FDA Finalizes Health Claim Associating Consumption of Barley Products with Reduction of Risk of Coronary Heart Disease The Food and Drug Administration announced that it has finalized a rule that allows foods containing barley to claim that they reduce the risk of coronary heart disease. whole grain barley and dry milled barley products such as flakes, grits, flour, and pearled barley, which provide at least 0.75 grams of soluble fiber per serving, may bear the following claim: ""Soluble fiber from foods such as [name of food], as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. A serving of [name of food] supplies [x] grams of the soluble fiber necessary per day to have this effect." FDA Finalizes Health Claim Associating Consumption of Barley Products with Reduction of Risk of Coronary Heart Disease The Food and Drug Administration announced that it has finalized a rule that allows foods containing barley to claim that they reduce the risk of coronary heart disease. whole grain barley and dry milled barley products such as flakes, grits, flour, and pearled barley, which provide at least 0.75 grams of soluble fiber per serving, may bear the following claim: ""Soluble fiber from foods such as [name of food], as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. A serving of [name of food] supplies [x] grams of the soluble fiber necessary per day to have this effect." FDA Finalizes Health Claim Associating Consumption of Barley Products with Reduction of Risk of Coronary Heart Disease The Food and Drug Administration announced that it has finalized a rule that allows foods containing barley to claim that they reduce the risk of coronary heart disease. whole grain barley and dry milled barley products such as flakes, grits, flour, and pearled barley, which provide at least 0.75 grams of soluble fiber per serving, may bear the following claim: ""Soluble fiber from foods such as [name of food], as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. A serving of [name of food] supplies [x] grams of the soluble fiber necessary per day to have this effect." FDA Finalizes Health Claim Associating Consumption of Barley Products with Reduction of Risk of Coronary Heart Disease The Food and Drug Administration announced that it has finalized a rule that allows foods containing barley to claim that they reduce the risk of coronary heart disease. whole grain barley and dry milled barley products such as flakes, grits, flour, and pearled barley, which provide at least 0.75 grams of soluble fiber per serving, may bear the following claim: ""Soluble fiber from foods such as [name of food], as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. A serving of [name of food] supplies [x] grams of the soluble fiber necessary per day to have this effect." FDA Finalizes Health Claim Associating Consumption of Barley Products with Reduction of Risk of Coronary Heart Disease The Food and Drug Administration announced that it has finalized a rule that allows foods containing barley to claim that they reduce the risk of coronary heart disease. whole grain barley and dry milled barley products such as flakes, grits, flour, and pearled barley, which provide at least 0.75 grams of soluble fiber per serving, may bear the following claim: ""Soluble fiber from foods such as [name of food], as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. A serving of [name of food] supplies [x] grams of the soluble fiber necessary per day to have this effect." FDA Finalizes Health Claim Associating Consumption of Barley Products with Reduction of Risk of Coronary Heart Disease The Food and Drug Administration announced that it has finalized a rule that allows foods containing barley to claim that they reduce the risk of coronary heart disease. whole grain barley and dry milled barley products such as flakes, grits, flour, and pearled barley, which provide at least 0.75 grams of soluble fiber per serving, may bear the following claim: ""Soluble fiber from foods such as [name of food], as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. A serving of [name of food] supplies [x] grams of the soluble fiber necessary per day to have this effect." FDA Finalizes Health Claim Associating Consumption of Barley Products with Reduction of Risk of Coronary Heart Disease The Food and Drug Administration announced that it has finalized a rule that allows foods containing barley to claim that they reduce the risk of coronary heart disease. whole grain barley and dry milled barley products such as flakes, grits, flour, and pearled barley, which provide at least 0.75 grams of soluble fiber per serving, may bear the following claim: ""Soluble fiber from foods such as [name of food], as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. A serving of [name of food] supplies [x] grams of the soluble fiber necessary per day to have this effect." Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology. Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology. Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology. Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology. Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology. Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology. Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology. Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology. Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods. Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods. Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods. Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods. Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods. Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods. Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods. FWS Restores 5-Year Minimum Age for Exported American Ginseng The US Fish & Wildlife Service (FWS) has just announced that the export of wild American ginseng (Panax quinquefolius) roots that are at least 5 years old “will not be detrimental to the survival of the species,” and so will be allowed to be exported from states that maintain ginseng programs during the next three harvest seasons (2006–2008). FWS Restores 5-Year Minimum Age for Exported American Ginseng The US Fish & Wildlife Service (FWS) has just announced that the export of wild American ginseng (Panax quinquefolius) roots that are at least 5 years old “will not be detrimental to the survival of the species,” and so will be allowed to be exported from states that maintain ginseng programs during the next three harvest seasons (2006–2008). Enzymotec Receives NDI status for CardiaBeat(TM) Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status. Enzymotec Receives NDI status for CardiaBeat(TM) Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status. Enzymotec Receives NDI status for CardiaBeat(TM) Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status. Enzymotec Receives NDI status for CardiaBeat(TM) Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status. Enzymotec Receives NDI status for CardiaBeat(TM) Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status. Enzymotec Receives NDI status for CardiaBeat(TM) Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status. NIH Multivitamin/ Mineral Supplements Conference Report This conference summary was prepared by UNPA's Steve Ferraro, providing insights and commentary on the recent NIH Consensus Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention. NIH Multivitamin/ Mineral Supplements Conference Report This conference summary was prepared by UNPA's Steve Ferraro, providing insights and commentary on the recent NIH Consensus Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention. NIH Multivitamin/ Mineral Supplements Conference Report This conference summary was prepared by UNPA's Steve Ferraro, providing insights and commentary on the recent NIH Consensus Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention. NIH Multivitamin/ Mineral Supplements Conference Report This conference summary was prepared by UNPA's Steve Ferraro, providing insights and commentary on the recent NIH Consensus Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention. Introduction of S. 3546 The Dietary Supplement and Non-Prescription Drug Consumer Protection Act UNPA hailed the introduction in the United States Senate of bipartisan legislation to mandate the reporting of serious adverse events related to the consumption of dietary supplements, the 'Dietary Supplement and Non-Prescription Drug Consumer Protection Act', introduced by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL), Tom Harkin (D-IA), Mike Enzi (R-WY) and Edward Kennedy (D-MA). Introduction of S. 3546 The Dietary Supplement and Non-Prescription Drug Consumer Protection Act UNPA hailed the introduction in the United States Senate of bipartisan legislation to mandate the reporting of serious adverse events related to the consumption of dietary supplements, the 'Dietary Supplement and Non-Prescription Drug Consumer Protection Act', introduced by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL), Tom Harkin (D-IA), Mike Enzi (R-WY) and Edward Kennedy (D-MA). Introduction of S. 3546 The Dietary Supplement and Non-Prescription Drug Consumer Protection Act UNPA hailed the introduction in the United States Senate of bipartisan legislation to mandate the reporting of serious adverse events related to the consumption of dietary supplements, the 'Dietary Supplement and Non-Prescription Drug Consumer Protection Act', introduced by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL), Tom Harkin (D-IA), Mike Enzi (R-WY) and Edward Kennedy (D-MA). Introduction of S. 3546 The Dietary Supplement and Non-Prescription Drug Consumer Protection Act UNPA hailed the introduction in the United States Senate of bipartisan legislation to mandate the reporting of serious adverse events related to the consumption of dietary supplements, the 'Dietary Supplement and Non-Prescription Drug Consumer Protection Act', introduced by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL), Tom Harkin (D-IA), Mike Enzi (R-WY) and Edward Kennedy (D-MA). Introduction of S. 3546 The Dietary Supplement and Non-Prescription Drug Consumer Protection Act UNPA hailed the introduction in the United States Senate of bipartisan legislation to mandate the reporting of serious adverse events related to the consumption of dietary supplements, the 'Dietary Supplement and Non-Prescription Drug Consumer Protection Act', introduced by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL), Tom Harkin (D-IA), Mike Enzi (R-WY) and Edward Kennedy (D-MA). CRN Applauds Senators On AER Bill Introduction CRN commends Senators Orrin Hatch (R-Utah), Tom Harkin (D-Iowa) and Richard Durbin (D-Ill.) for introducing S. 3546, “Dietary Supplement and Nonprescription Drug Consumer Act,” a bill that would require manufacturers to notify FDA of all serious adverse events (AEs) for dietary supplements and over-the-counter drugs (OTCs) reported to them. CRN Applauds Senators On AER Bill Introduction CRN commends Senators Orrin Hatch (R-Utah), Tom Harkin (D-Iowa) and Richard Durbin (D-Ill.) for introducing S. 3546, “Dietary Supplement and Nonprescription Drug Consumer Act,” a bill that would require manufacturers to notify FDA of all serious adverse events (AEs) for dietary supplements and over-the-counter drugs (OTCs) reported to them. Introduction of AER Bill in U.S. Senate Announced A press conference was held in the U.S. Capitol today to announce the introduction of legislation that will require companies that sell dietary supplements and over-the-counter drugs to submit serious adverse event reports that they receive from their customers to the Food and Drug Administration. The Dietary Supplement and Nonprescription Drug Consumer Protection Act (S. 3546), supported by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL) and Tom Harkin (D-IA), will require companies to include on their products’ labels an address or phone number through which consumers can report adverse events that they associate with their use of a supplement or OTC drug. Companies will be obliged to inform FDA of any serious adverse event reports they receive within 15 business days. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	MONTREAL, May 23 /CNW Telbec/ - BioEnvelop Technologies Corporation (the "Company" or "BioEnvelop") (BIE - TSX Venture Exchange) is pleased to announce that it has received a license to manufacture under the Natural Health Products (NHP) certification program of Canada. In gaining a license with NHP, a certification program administered by Health Canada, BioEnvelop can now manufacture Neutraceutical products at its St.-Hyacinthe facility that are approved as safe, effective, and of high quality as recognized by NHP Regulations which came into effect January 1, 2004. In addition, the certification program is a precursor for obtaining the Drug Establishment Licence (DEL) which will allow BioEnvelop to produce OTC and prescription drug products that can be sold throughout Canada and in most parts of the European Union. "Gaining an NHP through the Natural Health Products Directorate of Health Canada is a key strategic achievement for BioEnvelop. It gains us much credibility with Canadian consumers of Neutraceutical products and sets the company up for approval to sell OTC and prescription drug products in Canada," said Howard Pate, President and Chief Executive Officer of BioEnvelop Technologies Corporation. "The impending DEL from Health Canada will open the door to the Canadian Drug market as well," added Pate. As part of the Health Products and Food Branch of Health Canada, the Natural Health Products Directorate (NHPD) is the regulating authority for natural health products for sale in Canada. ABOUT BIOENVELOP ---------------- Founded in 1998, BioEnvelop Technologies Corporation (www.bioenvelop.com) has developed innovative core competencies in fast dissolving nutraceutical and pharmaceutical film and edible gels containing actives. The company is focused on advanced product delivery systems in the form of edible film strips and gels for the Health Food, OTC Drugs and Pharmaceutical Industries. BioEnvelop has a license to manufacture under the Natural Health Products (NHP) certification program of Canada and it is registered with the U.S. Food & Drug Administration (FDA) under Title 21, Part 207 of the Code of Federal Regulations (CFR), for the manufacturing of commercial drug products. Although the primary focus is on films and gels, the company continues to produce and market its line of edible and biodegradable food-agricultural coating solutions such as Longevita(R), Bari-Kad(R) and Miracle Glaçage(R). Longevita(R) is being further developed under license to Mitsubishi-Kagaku Foods in Japan for the Asia Pacific Market. FORWARD LOOKING STATEMENTS -------------------------- Certain statements in this news release contain forward looking statements, which by their nature are necessarily subject to risks and uncertainties that could result in important divergences between predicted and actual results. Such statements reflect the Company's current views with respect to future events, and are based on information currently available to the Company and on hypotheses which it considers to be reasonable; however, management warns the reader that hypotheses relative to future events, several of which are beyond the control of management, could prove to be false, given that they are subject to certain risks and uncertainties. Management declares that it has neither the intention nor the duty to provide public updates for each forward looking statement as a result of new information, new events or for any other reason and that such statements are made as of the date of this news release. The TSX Venture Exchange has neither approved nor disapproved of this news release.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software